Using the electroencephalographic (EEG) fingerprint to define the clinical pharmacodynamics (PD) of a novel opioid: Application to remifentanil (REMI) Egan, T. D., Muir, K. T., Stanski, D. R., Shafer, S. L. NATURE PUBLISHING GROUP. 1996: PI1–PI1

View details for Web of Science ID A1996TX00100001